earnings
confidence high
sentiment neutral
materiality 0.80
QuidelOrtho Q3 revenue $700M (-4% YoY); GAAP loss $10.78/sh on $701M impairment; Adj EPS $0.80
QuidelOrtho Corp
2025-Q3 EPS reported
-$14.79
revenue$2,006,600,000
- Total revenue $700M, down 4% YoY; non-respiratory revenue up 5% as reported, 6% constant currency ex-Donor Screening.
- GAAP net loss $733M includes $701M non-cash goodwill impairment; GAAP diluted EPS loss $10.78; adjusted diluted EPS $0.80.
- Adjusted EBITDA $177M, margin 25%, up 180 bps YoY driven by cost-savings initiatives.
- FY2025 guidance narrowed: revenue $2.68-$2.74B, adjusted EBITDA $585-$605M, adjusted diluted EPS $2.00-$2.15.
- Completed debt refinancing to improve financial flexibility with reduced amortization; terms not detailed.